Stroke recurrence and its prevention in patients with patent Foramen ovale

被引:36
作者
Harrer, JU
Wessels, T
Franke, A
Lucas, S
Berlit, R
Klötzsch, C
机构
[1] RWTH Aachen Univ Hosp, Dept Neurol, D-52074 Aachen, Germany
[2] RWTH Aachen Univ Hosp, Med Clin 1, Dept Cardiol, D-52074 Aachen, Germany
[3] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany
[4] Alfred Krupp Hosp, Dept Neurol, Essen, Germany
关键词
D O I
10.1017/S0317167100004674
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is unclear whether medical or invasive (surgical or catheter interventional) treatment is preferable to prevent recurrence of cerebral ischemia in patients with patent foramen ovale (PFO) as the Suspected cause of stroke and what the role of concomitant risk factors is in stroke recurrence. Methods: Over it period of ten years, 124 patients (mean age 5 1 15 years) with cryptogenic cerebral ischemia and PFO were included into the Study and prospectively followed over a mean of 52 32 months. Of these, 83 were treated medically, 34 underwent transcatheter closure, and seven had surgical closure of the foramen. Of the medically treated patients, 11 stopped medication during follow-up. Recurrent ischemic events and risk factors for recurrence were analyzed. Results: Annual stroke recurrence rates were generally low and comparable in catheter and medically treated patients, and in patients who had stopped medication (2.9%/2.1%/2.2%/ycar). Patients suffering from recurrence after transcatheter closure (n=2) both had residual shunts. No stroke recurrence was observed in the few surgically treated patients. An atrial septal aneurysm was not a predictor of recurrent or multiple strokes (p > 0.05, OR=0.31, and OR=0.74). Large shunts and a history of previous ischemic events were considerably more frequent in patients with recurrent strokes (p < 0.05, OR=5.0, and OR=4.4). Pulmonary embolism and case fatality rates were significantly higher in patients with stroke recurrence (p < 0.001, and p < 0.01). Conclusions: The absolute risk of recurrent cerebrovascular events in patients with PFO receiving medical or catheter interventional therapy is low. The small group of untreated patients had a comparably low rate of stroke recurrences. Previous ischemic events and shunt size were risk factors in this observational study. Given conflicting findings across multiple Studies, enrollment into a randomized controlled trial Would be the optimal choice.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
[1]   Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale [J].
Anzola, GP ;
Zavarize, P ;
Morandi, E ;
Rozzini, L ;
Parrinello, G .
EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (02) :129-135
[2]  
Beitzke A, 2001, J Interv Cardiol, V14, P223, DOI 10.1111/j.1540-8183.2001.tb00740.x
[3]   Prevention of stroke recurrence with presumed paradoxical embolism [J].
Bogousslavsky, J ;
Devuyst, G ;
Nendaz, M ;
Yamamoto, H ;
Sarasin, F .
JOURNAL OF NEUROLOGY, 1997, 244 (02) :71-75
[4]   Stroke recurrence in patients with patent foramen ovale: The Lausanne Study [J].
Bogousslavsky, J ;
Garazi, S ;
Jeanrenaud, X ;
Aebischer, N ;
VanMelle, G .
NEUROLOGY, 1996, 46 (05) :1301-1305
[5]   Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism - Periprocedural safety and mid-term follow-up results of three different device occluder systems [J].
Braun, M ;
Gliech, V ;
Boscheri, A ;
Schoen, S ;
Gahn, G ;
Reichmann, H ;
Haass, M ;
Schraeder, R ;
Strasser, RH .
EUROPEAN HEART JOURNAL, 2004, 25 (05) :424-430
[6]   Transcatheter closure of patent foramen ovale in patients with cerebral ischemia [J].
Braun, MU ;
Fassbender, D ;
Schoen, SP ;
Haass, M ;
Schraeder, R ;
Scholtz, W ;
Strasser, RH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :2019-2025
[7]   Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism - Single-center experience [J].
Bruch, L ;
Parsi, A ;
Grad, MO ;
Rux, S ;
Burmeister, T ;
Krebs, H ;
Kleber, FX .
CIRCULATION, 2002, 105 (24) :2845-2848
[8]   ATRIAL SEPTAL ANEURYSM AND PATENT FORAMEN OVALE AS RISK-FACTORS FOR CRYPTOGENIC STROKE IN PATIENTS LESS-THAN 55 YEARS OF AGE - A STUDY USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY [J].
CABANES, L ;
MAS, JL ;
COHEN, A ;
AMARENCO, P ;
CABANES, PA ;
OUBARY, P ;
CHEDRU, F ;
GUERIN, F ;
BOUSSER, MG ;
DERECONDO, J .
STROKE, 1993, 24 (12) :1865-1873
[9]   Increased pelvic vein thrombi in cryptogenic stroke - Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study [J].
Cramer, SC ;
Rordorf, G ;
Maki, JH ;
Kramer, LA ;
Grotta, JC ;
Burgin, WS ;
Hinchey, JA ;
Benesch, C ;
Furie, KL ;
Lutsep, HL ;
Kelly, E ;
Longstreth, WT .
STROKE, 2004, 35 (01) :46-50
[10]  
Cujec B, 1999, CAN J CARDIOL, V15, P57